Subacute cutaneous lupus erythematosus (SCLE) is a subset of cutaneous lupus erythematosus with unique immunologic and clinical features. The first description dates back to 1985 when a series of five patients were found to have hydrochlorothiazide-induced SCLE. Since that time, at least 40 other drugs have been implicated in the induction of SCLE. Lupus (2010) 19, 1107— 1111.
Sontheimer RD , Thomas JR, Gilliam JNSubacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol1979; 115: 1409-1415.
2.
Sontheimer RD , Maddison PJ, Reichlin M., Jordon RE, Stastny P., Gilliam JNSerologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med1982 ; 97: 664.
3.
Black DR, Hornung CA, Schneider PD, Callen JPFrequency and severity of systemic disease in patients with subacute cutaneous lupus erythematosus. Arch Dermatol2002; 138: 1175-1178.
4.
Reed BR, Huff JC, Jones SK, Orton PW, Lee LA, Norris DASubacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Ann Intern Med1985; 103: 49-51.
Srivastava M., Rencic A., Diglio G., et al. Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus. Arch Dermatol2003; 139: 45-49.
13.
Darken M., McBurney E.Subacute cutaneous lupus erythematosus-like drug eruption due to combination diuretic hydrochlorothiazide and triamterene. J Am Acad Dermatol1988; 18: 38-42.
14.
Leroy D., Dompmartin A., Le Jean S., Guillemain J., Mandard J., Deschamps P.Dermatitis caused by aldactone of a lupic annular erythema type. Ann Dermatol Venereol1987; 114: 1237-1240 (French).
15.
Crowson A., Magro C.Subacute cutaneous lupus erythematosus arising in the setting of a calcium channel blocker therapy. Hum Pathol1997; 28: 67-73.
16.
Crowson A., Magro C.Diltiazem and subacute cutaneous lupus erythematosus-like lesions . N Engl J Med1995; 333: 1429.
17.
Gubinelli E. , Cocuroccia B., Girolomoni G.Subacute cutaneous lupus erythematosus induced by nifedipine. J Cutan Med Surg2003; 7: 243.
18.
Marzano A., Borghi A., Mercogliano M., Facchetti M., Caputo R.Nitrndipine-induced subacute cutaneous lupus erythematosus. Eur J Dermatol2003; 13: 213-216.
19.
Patri P., Nigro A., Rebora A.Lupus erythematosus-like eruption from captopril. Acta Derm Venereol1985; 65: 447-448.
20.
Fernandez-Diaz M., Herranz P., Suarez-Marrero M., Borbujo J., Manzano R., Casado M.Subacute cutaneous lupus erythematosus associated with cilazapril. Lancet1995; 345: 398.
Hill V., Chow J., Cowley N., Marsden R.Subacute lupus erythematosus-like eruption due to terbinafine: report of three cases. Br J Dermatol2003; 148: 1056.
26.
Bonsmann G. , Schiller M., Luger T., Stander S.Terbinafine-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol2001; 44: 925-931.
McKellar G. , Porter D., Burden D.Terbinafine as a cause of cutaneous lupus erythematosus. Rheumatology2004; 43: 249.
29.
Terreb Z., El Ouzzani T., Zouhair K., El Kabli H., Lakhdar H.Syndrome de Stevens-Johnson et aggravation d’n lupus systemique induits par la terbinafine. Ann Dermatol Venereol2006; 133: 463-466.
30.
Fahri D., Viguier M., Cosnes A., et al. Terbinafine-induced subacute cutaneous lupus erythematosus. Dermatology2006; 212: 59-65.
31.
Cetkovská P., Pizinger K.Coexisting subacute and systemic lupus treatment with mycophenolate mofetil. Int J Dermatol2006; 45: 320-322.
32.
Lorentz K., Booken N., Goerdt D., Goebeler M.Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature. J Dtsch Dermatol Ges2008; 6: 823-828.
33.
Bleumink G. , ter Borg E., Ramselaar C., Ch Stricker B.Etanercept-induced subacute cutaneous lupus erythematosus. Rheumatology2001; 40: 1317-1319.
34.
Brion P., Mittal-Henkle A., Kalunian K.Autoimmune skin rashes associated with etanercept for rheumatoid arthritis . Ann Intern Med1999; 131: 634.
35.
Carlson E., Rothfield N.Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis . Arthritis Rheum2003; 48: 1165-1166. (author reply 1166).
36.
De Bandt M. , Descamps V., Meyer O.Two cases of etanercept-induced lupus-like syndrome in ra patients. Arthritis Rheum2001 ; 44: S372.
37.
Klapman J., Ene-Stroescu D., Becker M., Hanauer S.A lupus-like syndrome associated with infliximab therapy. Inflamm Bowel Dis2003; 9: 176-178.
38.
Stratigos AJ , Antoniou C., Stamathioudaki S., Avgerinou G., Tsega A., Katsambas ADDiscoid lupus erythematosus-like eruption induced by infliximab. Clin Exp Dermatol2004; 20: 150-153.
39.
Schneider SW , Staender S., Schüter B., Luger TA, Bonsmann G.Infliximab-induced lupus erythematosus tumidus in a patient with rheumatoid arthritis. Arch Dermatol2006; 142: 115-156.
Nousari H., Kimyai-Asadi A., Tausk F.Subacute cutaneous lupus erythematosus associated with interferon beta-1a . Lancet1998; 352: 1825-1826.
44.
Arrue I., Saiz A., Ortiz-Romero PL, Rodríguez-Peralto JLLupus-like reaction to interferon at the injection site: report of five cases . J Cutan Pathol2007; 34(Suppl 1): 18-21.
45.
Bentley DD, Graves JE, Smith DI, Heffernan MPEfalizumabinduced subacute cutaneous lupus erythematosus. J Am Acad Dermatol2006; 54: s242-s243.
46.
Miyagawa S. , Okuchi T., Shiomi Y., Sakamoto K.Subacute cutaneous lupus erythematosus lesions precipitated by griseofulvin. J Am Acad Dermatol1989; 21: 343-346.
47.
Miyagawa S. , Sakamoto K.Adverse reactions to griseofulvin in patients with circulating anti-SS-A/Ro and SS-B/La autoantibodies. Am J Med1989; 87: 100-102.
48.
Dowdy M., Nigra T., Barth W.Subacute cutaneous lupus erythematosus during PUVA therapy for psoriasis: case report and review of the literature. Arthritis Rheum1989; 32: 343-346.
49.
Neumann C.Induktion eines subakuten kutanen lupus erythematodes durch psorale UV-A-therapie . Z. Hautkr1987; 62: 1523-1524, 1527-1528.
50.
Brenner W., Gschnait F.Cinnarizin-ein bisher unbekannter induktor eines lupus-erythematodes-ahnlichen syndroms. Der Hautarzt1978; 29: 392-394.
51.
Toll A., Campo-Pisa P., Gonzalez-Castro J., et al. Subacute cutaneous lupus erythematosus associated with cinnarizine and thiethylperazine therapy. Lupus1998; 7: 364-366.
52.
Noël B.Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review. J Eur Acad Dermatol Venereol2007; 21: 17-24.
Jian X., Guo G., Ruan Y., Lin D., Li X.Severe cutaneous adverse drug reaction to leflunomide: a report of two cases . Cutan Ocul Toxicol2008; 27: 5-9.
56.
Gensburger D. , Kawashima M., Marotte H., Kanitakis J., Miossec P.Lupus erythematosus with leflunomide: induction or reactivation?
57.
Marazano AV , Ramoni S., Del Papa N., Barbareschi M., Alessi E.Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions. Lupus2008; 17: 329-331.
58.
Chen M., Crowson A., Woofter M., Luca M., Magro C.Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases. J Rheumatol2004; 31: 818-820.
59.
Adachi A., Horikawa T.Paclitaxel-indcued cutaneous lupus erythematosus in patients with serum anti-SSA/Ro antibody. J Dermatol2007 ; 34: 473-476.
60.
Ross S., Ormerod A., Roberts C., Dwyer C., Herriot R.Subacute cutaneous lupus erythematosus associated wit phenytoin. Clin Exp Dermatol2002; 27: 474-476.
61.
Ghate J., Turner M., Rudek M., et al. Drug-induced lupus associated with col-3: report of 3 cases . Arch Dermatol2001; 137: 471-474.
62.
Balsa A., Bernad M., de Miguel E., Crespo. Lupus eritematoso cutaneo subagudo inducido por la crisoterapia en una arthritis reumatoide. Revista Clinica Espanola1988; 182: 505-506.
63.
Parodi A., Rivara G., Guarrera M.Possible naproxen-induced relapse of subacute cutaneous lupus erythematosus . JAMA1992; 268: 51-52.
64.
Roura M., Lopez-Gil F., Umbert P.Systemic lupus erythematosus exacerbated by piroxicam. Dermatologica1991; 182: 56-58.
65.
Sharpiro M. , Sosis A., Junkins-Hopkins J., Werth V.Lupus erythematosus induced by medications, ultraviolet radiation, and other exogenous agents: a review, with special focus on the development of subacute cutaneous lupus erythematosus in a genetically predisposed individual. Int J Dermatol2004; 43: 87-94.
66.
Crowson A., Magro C.Lichenoid and Subacute cutaneous lupus erythematosus-like dermatitis associated with antihistamine therapy. J Cutan Pathol1999; 26: 95-99.
Popovic K., Wahren-Herlenius M., Nyberg F.Clinical follow-up of 102 Anti-Ro/SS-A-positive patients with dermatologic manifestations. Acta Derm Venereol2008; 88: 370-375.
71.
Capponi A., De Simone C., Guerriero C., Rotoli M., Bartoloni C.Ro/SSA-positive cutaneous lupus erythematosus induced by carbamazepine . Arch Dermatol2005; 141: 103-104.
72.
Amerio P., Innocente C., Feliciani C., Angelucci D., Gambi D., Tulli A.Drug-induced cutaneous lupus erythematosus after 5 years of treatment with carbamazepine. Eur J Dermatol2006; 16: 281-283.
73.
Fumal I., Danchin A., Cosserat F., Barbaud A., Schmutz JLSubacute cutaneous lupus erythematosus associated with tamoxifen therapy: two cases. Dermatology2006; 210: 251-252.
74.
Adachi A., Nagai H., Horikawa T.Anit-SSA/Ro antibody as a risk factor for fluorouracil-induced drug eruptions showing acral erythema and discoid-lupus-erythematosus-like lesions . Dermatology2007; 214: 85-88.
75.
Weger W., Kränke B., Gerger A., Salmhofer W., Aberer E.Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine. J Am Acad Dermatol2008; 59: s4-s6.
76.
Wiechert A. , Tüting T., Bieber T., Haidl G., Wenzel J.Subacute cutaneous lupus erythematosus in a leuprorelin-treated patient with prostate carcinoma . Br J Dermatol2008; 159: 231-232.
77.
Reich A., Bialynicki-Birula R., Szepietowski JCDrug-induced subacute cutaneous lupus erythematosus resulting from ticlopidine . Int J Dermatol2006; 45: 1112-1114.
Funke AA, Kulp-Shorten CL, Callen JPSubacute cutaneous lupus erythematosus exacerbated by or induced by doxorubicin hydrochloride. Archives of Dermatology 2009.
